Hematology & Oncology
Division of Hematology and Oncology
Benign Hematology
The goals of the clinical program are to provide: 1) inpatient consultative hematology services to both medical and surgical specialties; 2) to provide outpatient consultative hematology for referring physicians in Florida, Southern Georgia and Alabama 3) to provide primary hematologic care for patients with both benign and malignant hematologic conditions at Shands Hospital and the Malcom Randall Veterans Administration Medical Center. Areas of expertise include hemostasis, thrombosis, immune cytopenias, primary bone marrow disorders, iron metabolism, sickle cell disease, and therapeutic apheresis. The hematology service has a major role in providing consultations pertaining to blood transfusion issues. Administrative activities include oversight of therapeutic apheresis for the regional blood services system and the Shands Hospital Anticoagulation Clinic. The hematology group have a major commitment to educational activities for medical students, residents, fellows. and continuing education venues. The faculty has attained local, regional and national recognition for these efforts.
Faculty:
Craig Kitchens, MD, MACP
Professor
He is a national/international expert in consultative hemostasis/thrombosis. He is the Chief of Staff for Education at Malcom Randall Veterans Administration Medical Center. He has a major role in the teaching programs of the Department of Medicine including oversight for the Shands Hospital morning report and Morbidity/Mortality conferences. He is recognized as an outstanding teacher in the College of Medicine. He serves as the current Governor of the American College of Physicians for Florida. Dr. Kitchens’ clinical activities are at the VA Medical Center providing oversight of the Hematology Consultation service and providing Hematology new patient and follow-up at Shands Hospital Hematology clinic. He also attends the Shands Hospital inpatient hematology consultation service and is an attending physician on the VA General Medicine ward services. He was awarded a Mastership in the American College of Physicians (MACP) in 2007, and is an immediate past Governor of ACP Florida.
Richard Lottenberg, MD, FACP
Professor and Program Director Fellowship Training Program
His current investigative activities are in health services research in Sickle Cell Disease. The primary areas of focus are enhancing the uptake of evidence-based treatment approaches for adult patients and improving the use of hydroxyurea therapy in high risk patients. Dr. Lottenberg has been a faculty mentor for numerous students and post-doctoral trainees. American Society of Hematology activities include membership on the Optimization of Hematologic Care Committee (2000-2002) and Committee on Governmental Affairs (2005 -2008); faculty participant in the Clinical Research Training Institute (2004 and 2006); co-author for the section on hemolytic anemias for the Self Assessment Program (2003 and 2005) and the web-based Evidence-based Medicine module. He is an associate editor of an Evidence-based Hematology textbook to be published in 2008. Dr. Lottenberg’s clinical activities are primarily at Shands Hospital including oversight of the Adult Sickle Cell Program, attending the inpatient hematology consultation service and outpatient hematology clinics. He is the medical team leader in the Shands-UF hospital wide initiative in venous thromboembolism prophylaxis.
Marc Zumberg, MD
Associate Professor
Dr. Zumberg is recognized as outstanding clinician - educator in the Division of Hematology/Oncology and the Department of Medicine. He serves the majority of his time as an attending physician the inpatient hematology consultation service at Shands Hospital. Dr. Zumberg also provides outpatient, new patient and follow-up services at the outpatient Davis Cancer center. He serves as the Medical Director of Therapeutic Apheresis for Lifesouth, the regions blood provider. He is also the Medical Director for the Shands –UF outpatient Anticoagulation Clinic. Dr. Zumberg serves as chairman for the transfusion committee at Shands hospital. Dr. Zumberg gives lectures for local and regional internal medicine and hematology/oncology continuing education programs and has co-authored sections on iron metabolism, hemolytic anemia, and underproduction anemias for the American Society of Hematology Self Assessment Program (2003 and 2005). He also has co-authored book chapters on topics pertaining to hemostasis and thrombosis. Dr. Zumberg has research interests in ITP, sickle cell disease, and other area of benign hematology.
Bradley Fletcher, MD, PhD
Assistant Professor, Department of Pharmacology and Therapeutics
Veterans Administration Advanced Career Development Awardee, American Heart Association Career Development Awardee and Florida Biomedical Research Program NIR Awardee. His major effort is focused on biomedical research using transposons as vehicles to facilitate longterm gene expression following non-viral gene delivery. This approach has been used to treat various conditions in animal models including hemophilia, pulmonary hypertension and acute graft rejection. Dr. Fletcher’s clinical activities include attending the inpatient hematology consultation service at Shands Hospital and outpatient clinical hematology and follow-up at both the Shands Hospital and the Malcom Randall Veterans Administration Medical Center.